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Characterization of Virus-Encoded RNA Interference Suppressors in
Caenorhabditis elegans
Xunyang Guo, Rui Lu
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA
In fungi, plants, and invertebrates, antiviral RNA interference (RNAi) directed by virus-derived small interfering RNAs (siRNAs)
represents a major antiviral defense that the invading viruses have to overcome in order to establish infection. As a counterde-
fense mechanism, viruses of these hosts produce diverse classes of proteins capable of suppressing the biogenesis and/or func-
tion of viral siRNAs. This RNA-directed viral immunity (RDVI) in the nematode Caenorhabditis elegans is known to exhibit
some unique features. Currently, little is known about viral suppression of RNAi in C. elegans. Here, we show that ectopic ex-
pression of the B2 protein encoded by Flock House virus (FHV) suppresses RNAi induced by either long double-stranded RNA
(dsRNA) or an FHV-based replicon and facilitates the natural infection of C. elegans by Orsay virus but is not active against RNA
silencing mediated by microRNAs. We report the development of an assay for the identification of viral suppressor of RNAi
(VSR) in C. elegans based on the suppression of a viral replicon-triggered RDVI by ectopic expression of candidate proteins. No
VSR activity was detected for either of the two Orsay viral proteins proposed previously as VSRs. We detected, among the known
heterologous VSRs, VSR activity for B2 of Nodamura virus but not for 2b of tomato aspermy virus, p29 of fungus-infecting hy-
povirus, or p19 of tomato bushy stunt virus. We further show that, unlike that in plants and insects, FHV B2 suppresses worm
RDVI mainly by interfering with the function of virus-derived primary siRNAs.
Viral suppressors of RNA silencing (VSRs) are a group of virus-encoded proteins that facilitate virus infection by suppressing
the antiviral immunity mediated by RNA interference (RNAi) (1).
Small interfering RNAs (siRNAs) derived from replicating viruses
guide sequence-specific antiviral RNAi in fungi, plants, and inver-
tebrates (2). Accumulating evidence suggested that most of virus-
derived siRNAs are processed from viral replication intermedi-
ates, in the form of double-stranded RNAs (dsRNAs), by Dicer
proteins, a class of RNase III RNases (3). siRNA-mediated silenc-
ing of invading viruses culminates with the cleavage of viral tran-
scripts by Argonaute (AGO) proteins which recruit siRNAs as a
sequence guide for target RNA selection and slice the matching
RNA molecules with their RNase H-like activity (2). In plants and
the nematode worm Caenorhabditis elegans, RNA-dependent
RNA polymerases (RdRPs) are essential for this RNA-directed
viral immunity (RDVI) by amplifying siRNAs (4–6).
Since RDVI is mediated by siRNAs processed from replicating
viral genomes, the chance for the targeted viruses to evade RDVI
through generating genome variants is low. Therefore, one of the
major strategies for the targeted viruses to establish successful in-
fection is to produce VSRs. VSRs are diverse, in term of sequence
and structure, classes of proteins encoded by fungus, plant, and
animal viruses with DNA or RNA genome and target viral or host
factors to suppress the biogenesis and/or function of siRNAs (7).
For example, the B2 proteins produced by Flock House virus
(FHV) or Nodamura virus (NoV) have been shown to bind long
dsRNAs, thereby suppressing the processing of dsRNAs into
siRNAs by Dicer, whereas the p19 protein of tomato bushy stunt
virus (TBSV) and the 2b protein of tomato aspermy virus (TAV)
specifically bind and inhibit the function of 21-nucleotide (nt)
siRNAs (8–14). The fact that TBSV p19 is an active suppressor of
RNAi in both insect and mammalian cells suggests that its func-
tion does not require host factors (15–17). In plants, VSRs are
capable of interfering with the function of microRNAs (miRNAs),
a class of endogenous small noncoding RNAs with important
functions in development and stress response (18–20). miRNAs
are encoded by nuclear genes and their biogenesis requires Dicer
proteins and cofactors. Accumulating evidence suggests that sup-
pression of miRNA function by VSRs is responsible for the devel-
opmental defects induced by plant virus infection (21, 22).
Development of RDVI suppression assays has played an im-
portant role in the discovery and characterization of VSRs and the
study of VSR-mediated virus-host interaction (1). The early assays
surveyed suppression of transgene RNA silencing in plants by a
candidate viral protein expressed from either an infectious recom-
binant virus or a transgene (23–25). RNAi targeting a cellular gene
induced by synthetic long dsRNAs or siRNAs in animal cells was
similarly used for the identification of VSRs (17). Subsequently,
experimental systems were developed to directly assay for the sup-
pression of RNA silencing that is induced by and specifically tar-
gets a replicating virus in a host cell (26). Development of these
experimental systems was made possible by the detailed charac-
terization of mutant viruses or virus-based replicons from which a
cognate VSR was deleted. These VSR-deficient viruses and repli-
cons exhibit no defect in replication but accumulate to only low
levels in host cells because of robust and specific antiviral RNAi
induced by virus replication. However, abundant accumulation of
VSR-deficient viruses is restored in host cells defective in RDVI.
Therefore, a candidate viral protein is identified as a VSR when its
expression rescues the accumulation of a VSR-deficient mutant
virus or replicon after replication in a host cell.
C. elegans has recently emerged as an important animal model
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for the study of virus-host interaction, especially the antiviral im-
munity, in single-Dicer invertebrates (11, 27–31). RDVI in C.
elegans exhibits several distinct features. Current studies on C.
elegans RDVI suggest that the worm RDVI is initiated upon the
processing of viral dsRNAs into primary siRNAs by the single
worm Dicer, DCR-1, with the aid of a dsRNA binding protein
termed RDE-4 (30–32). Subsequently, RDE-1, an AGO protein,
recruits primary siRNAs as sequence reference for the target viral
transcript selection (33–35). As found in plants, the worm RDVI
also requires an RdRP termed RRF-1 (27, 30, 32). However, unlike
the plant RdRPs that produce secondary siRNAs with the help
from Dicer, RRF-1 functions downstream of RDE-1 and directs
unprimed synthesis of 22-nt single-stranded siRNAs with triphos-
phate group at the 5= end in a Dicer-independent manner (36–38).
In addition to AGO and RdRP proteins, the worm RDVI also
requires some components, such as RSD-2 and DRH-1, that are
not conserved in plants or insects. RSD-2 is a novel protein known
to contribute to chromosomal functions probably through facili-
tating the accumulation of secondary siRNAs (39, 40). DRH-1 is a
putative DEAD box RNA helicase that shares significant sequence
homology with RIG-I, a mammalian cytosolic virus sensor in in-
terferon-mediated antiviral immunity (32, 41). Interestingly,
DRH-1 appears to be a dedicated factor of RDVI in C. elegans since
RNA silencing targeting cellular transcripts occurs in a DRH-1-
independent manner (32). Besides, worm RDVI seems to be neg-
atively regulated by a mechanism that involves the degradation of
siRNAs (42).
Little is known about viral suppression of RDVI in C. elegans.
Recent studies have discovered naturally occurring virus that in-
fects and induces RDVI in C. elegans (27). However, it is unknown
whether the virus encodes VSR or VSR expression enhances virus
infection in C. elegans. Previously, B2 of FHV has been shown to
be required for efficient viral replication in wild-type worms but
not in worm mutants defective in RDVI (11), suggesting a func-
tion for FHV B2 in worm RDVI suppression. However, it remains
unknown whether ectopic expression of FHV B2 suppresses RNAi
induced by synthetic dsRNA or worm RDVI induced by FHV or
heterologous viruses. Here, using FHV B2 as a reference VSR, we
developed a robust RDVI suppression assay that allows for the
identification of VSRs with RDVI suppression activity in C.
elegans. Using this assay, we not only demonstrated that the Orsay
virus RNA2 encodes no RDVI suppression activity but also iden-
tified NoV B2 as a VSR that retained the RDVI suppression activ-
ity in worm. It was also clear from our study that FHV B2 mainly
inhibits the function, rather than the biogenesis, of virus-derived
primary siRNAs in C. elegans but is unable to suppress the func-
tion of worm miRNAs which use the same Dicer for biogenesis.
Intriguingly, we found that TBSV p19 is not an active RDVI sup-
pressor in C. elegans. Since TBSV p19 is known to specifically bind
and inhibit the function of 21-nt siRNAs, our observations sug-
gested 21-nt primary siRNAs may not make major contribution to
worm RDVI.
MATERIALS AND METHODS
Worm genetics. The Bristol isolate of C. elegans, N2, was used as the
reference strain in the present study. Other N2-derived mutants used in
the present study include rde-1 (ne300) and rrf-1 (pk1417). The genotype
of rde-1 worms was confirmed using skn-1 feeding RNAi combined with
genomic DNA sequencing. The genotype for rrf-1 allele pk1417 was iden-
tified using PCR as described previously (29). All worm strains were main-
tained using NGM plates seeded with Escherichia coli strain OP50 except
otherwise indicated. Standard genetic cross was used to deliver various
transgenes into different genetic backgrounds.
Plasmid constructs and transgenic worms. All constructs utilizing
the heat-inducible promoter were developed by inserting the target gene
into pPD49.83 utilizing the XmaI and SacI site. All constructs utilizing the
sur-5 promoter were developed by inserting the target gene into LR50
described previously (29). The coding sequences for TBSV p19 and TAV
2b were PCR amplified from corresponding T-DNA expression binary
constructs described previously (43, 44). The point mutations in p19m
and 2bm were introduced through PCR amplification of wild-type genes
using primers containing desired mutations. All resulting constructs were
confirmed through DNA sequencing. The construct used to drive gfp
dsRNA expression in E. coli was described previously (29).
Transgenic animals were generated through gonadal microinjection
of the target constructs. Briefly, the target plasmid constructs, each at a
final concentration of 10 ng/l, were mixed with the 2-log DNA ladder
(New England BioLabs, Inc.) at final concentration of 100 ng/l and the
reporter plasmid Pmyo-2::mcherry at final concentration 40 ng/l and
injected into the gonads of target worms. Generation of corresponding
chromosomal integrants and assay for viral replication were as described
previously (29).
Infectious filtrate preparation and Orsay virus inoculation. Orsay
virus was maintained using the JU1580 isolate at room temperature fol-
lowing a protocol described previously (27). To prepare Orsay virus in-
oculum, JU1580 worms infected with Orsay virus were washed off, using
M9 buffer, from slightly starved 10-cm plates, 5 ml per plate. The virus-
containing liquid was then filtered through a 0.22-m-pore-size filter
unit (Millipore), and the filtrate was used to resuspend pelleted OP50 E.
coli for NGM plate seeding.
RNAi experiments. The skin-1 and gfp feeding RNAi assay was per-
formed using a bacterial feeding protocol described previously (45).
Briefly, NGM agar plates containing 5 mM IPTG and 100 mg of carbeni-
cillin/ml were seeded with E. coli. HT115 expressing skn-1 or gfp dsRNAs.
Assay for miRNA biogenesis/function suppression activity. Worms
used in this assay contain a let-7 function reporter transgene, which con-
tains a green fluorescent protein (GFP) coding sequence fused with the
let-7 target sequence, namely, the 3= end untranslated region of lin-41, and
a transgene expressing the let-7 miRNAs. Both transgenes are driven by
the myo-2 promoter, and thus enhanced green fluorescence can be ob-
served in the pharynx tissue in worms defective in miRNA biogenesis
and/or function (46). The assay began with microinjection of plasmid
constructs containing candidate VSR coding sequence driven by the
myo-2 promoter into the reporter worm strain SX333 (obtained from the
Caenorhabditis Genetics Center). The PRF4 construct was coinjected to
produce the roller phenotype as a visual mark for the VSR transgene. After
microinjection, transgenic lines carrying transmittable extrachromo-
somal arrays were picked up and maintained at room temperature. For
each transgenic line, the green fluorescence in the pharynx tissue was
compared, at different developmental stages, in between worms that carry
the extrachromosomal array and worms that do not.
Protein and RNA gel blot analysis. Total proteins were extracted from
worms of mixed stages treated with or without heat induction and were
resolved on an 8% SDS-PAGE gel, electroblotted, and subjected to protein
gel blot analysis using either anti-HA (Cell Signaling Technology) or anti-
actin primary antibody (Sigma-Aldrich) and goat anti-rabbit secondary
antibody (Cell Signaling Technology). Total RNA extraction, small RNA
enrichment, viral genomic and subgenomic RNA detection, and siRNA
and miRNA detection were performed using protocols described previ-
ously (29). The detection of viral high molecular transcripts used probe
derived from the full-length of gfp cDNA. For FR1gfp siRNA detection,
the probes were prepared using 32 DNA oligonucleotides covering the
entire GFP region of FR1gfp. The detection of miR-58DNA used digoxi-
genin (DIG)-labeled oligonucleotide ATTGCCGTACTGAACGATCTCA
as a probe. Four DNA oligonucleotides of 19, 21, 23, or 25 nt were detected
Suppression of RNAi in C. elegans



























































using DIG-labeled cDNA oligonucleotides and, together with miR-58,
served as a size reference.
Terminator treatment of small RNA samples. The terminator treat-
ment was carried out by mixing 20 g of small RNA sample with 4 U of
terminator exonuclease (Epicentre, Inc.) in 50-l reaction mix containing
1 buffer and 1 U of RNase inhibitor. The reaction mix was then incu-
bated at 30°C for 60 min. For both treatments, the treated small RNA
samples were cleaned through extracting with phenol-chloroform and
then precipitated with ethanol.
Imaging microscopy. The green and red fluorescence images were
recorded using a Nikon digital camera p7000 mounted on a Nikon
SMZ1500 microscope.
RESULTS
FHV B2 suppresses dsRNA-triggered RNAi and RDVI targeting
a natural viral pathogen of C. elegans. Thus far, no VSR has been
shown to suppress classical RNAi triggered by long dsRNA in C.
elegans. FHV B2 retains its RNAi suppression activity when pro-
duced in trans in both plant and insect system (8, 26, 47). Despite
its insect origin, FHV B2 was shown to be required for efficient
replication of the cognate virus in the wild-type C. elegans but
became dispensable in worm mutants defective in RDVI (11),
suggesting that FHV B2 retains its RDVI suppression activity in
worms. To find out whether FHV B2 suppresses classical RNAi in
C. elegans, we assayed the silencing of a gfp transgene triggered by
ingestion of gfp dsRNA in worms carrying constitutively active
nuclear transgene corresponding to FHV B1 and FHV B2 (Fig.
1A). The B1 protein of FHV, which is translated from the same
subgenomic RNA as B2, is known to be inactive in RNAi suppres-
sion (47) and thus served as control to FHV B2 in our test. As
shown in Fig. 1B, silencing of the gfp transgene was suppressed in
transgenic worms expressing FHV B2 but not in wild-type N2
worms or worms expressing FHV B1, confirming that FHV B2
indeed suppresses long dsRNA-triggered RNAi in worms.
Orsay virus is a naturally occurring viral pathogen of C. elegans
that was originally isolated from a worm mutant defective in
RDVI (27). Interestingly, the replication of Orsay virus in wild-
type N2 worms is significantly weaker compared to that in RDVI-
defective mutants. The fact that Orsay virus is still sensitive to
RDVI suggested that its replication would be further enhanced in
worms expressing a functional VSR. To test this hypothesis, we
checked the Orsay virus infection in transgenic worms constitu-
tively expressing FHV B2. As shown in Fig. 1C, compared to that
in nontransgenic N2 worms and N2 worms expressing FHV B1,
the replication of Orsay virus was significantly enhanced in trans-
genic N2 worms expressing FHV B2. These results together sug-
gested that FHV B2 is able to suppress both long dsRNA-triggered
RNAi and RNAi triggered by natural viral infection in C. elegans.
Development of an assay for the identification of VSRs in C.
elegans. To facilitate the discovery and characterization of VSRs in
C. elegans, we developed an RDVI suppression assay based on the
induction of RDVI by the self-replication of the genomic RNA1 of
FHV. The construction of FR1gfp, an FHV RNA1-based replicon
that contains a GFP coding sequence in the place of B2 coding
sequence (Fig. 2A), was described previously (32). As shown pre-
viously, the replication of FR1gfp launched from a chromo-
somally integrated transgene is suppressed by RDVI in wild-type
worms but is restored to yield green fluorescence expressed from
the subgenomic RNA produced after RNA1 replication in RNAi-
defective mutant worms such as rde-1 and drh-1 mutants. We
determined whether the FR1gfp-induced RDVI was suppressed
and whether the expression of GFP was activated following ecto-
pic expression of a functional VSR. We chose the FHV B2 as the
VSR since it exhibits RNAi suppression activity following ectopic
expression in both plant and insect cells and suppresses FHV
RNA1-induced RDVI when encoded in cis (26, 47). In our exper-
imental system, two plasmid constructs were comicroinjected into
the gonads of young adult worms containing the FR1gfp replicon
(32), and GFP expression was monitored in the next generation of
worms. The first constructs directed expression of the FHV B2
driven by the same heat-inducible promoter used to initiate
FR1gfp replication (Fig. 2A). The second construct directed
mcherry expression in the pharynx tissue and was used to generate
a visible marker for transgene transformation. Most of the extra-
chromosomal transgenic arrays generated through gonad injec-
tion are randomly passed on to the next generations so that there
are always some worms within each generation of the transgenic
lines that are free of the transgene, marked by the absence of
mcherry expression. Therefore, progenies from a transformed
parent often include individuals that do not inherit the transgene,
and thus can serve as an internal negative control.
As shown in Fig. 1B, we found that all transgenic progenies
carrying the HIP::fB2 extrachromosomal arrays, marked by red
fluorescent in head, produced bright full body green fluorescence
in response to induction of FR1gfp replication through heat treat-
ment. However, no full body green fluorescence was observed in
the progenies carrying the transgenic arrays that directed expres-
sion of FHV B1, which was encoded by the same subgenomic RNA
as B2 but showed no VSR activity (47). To further verify these
findings, we generated chromosomal integrants for the FHV B1
and B2 transgenes and checked the accumulation of FR1gfp tran-
scripts in response to heat induction in respective transgenic
FIG 1 FHV B2 suppresses long dsRNA-triggered RNAi and RDVI targeting
Orsay virus. (A) Schematic structure of the sur-5 promoter-based transgenes.
Psur-5, the promoter for worm gene sur-5. UTR, the 3= end untranslated
sequence of the worm gene unc-54; fB1, B1 coding sequence of FHV; fB2, B2
coding sequence of FHV; GFP, the coding sequence of green fluorescence
protein. (B) FHV B2 suppresses dsRNA-triggered RNAi. All worms used in
this test contain a nuclear transgene corresponding to Psur-5::GFP. Shown
here is the accumulation of gfp transcripts in wild-type N2 worms or worms
containing Psur-5::fB1 or Psur-5::fB2 transgene as indicated. Asterisks denote
total RNA samples extracted from worms fed on E. coli food expressing GFP
dsRNA. Methylene blue-stained rRNA serves as an equal loading control. (C)
FHV B2 enhances the replication of Orsay virus. Shown here is the accumula-
tion of Orsay virus RNA1 in C. elegans isolate JU1580, wild-type N2 worms,
rde-1 mutants, and worms expressing FHV B1 and B2, respectively. Total RNA
was prepared 72 h after virus inoculation. A 1.2-kb cDNA fragment derived
from the 3= end of Orsay virus RNA1 was used to prepare probes for hybrid-
ization. Methylene blue-stained rRNA serves as an equal loading control.
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worms using Northern blot hybridization. As shown in Fig. 2C,
enhanced FR1gfp replication was detected in FHV B2 chromo-
somal integrants as found in the rde-1 mutant worms defective in
RDVI, but not in the integrants containing FHV B1 transgene.
These results together showed that ectopic expression of FHV B2
suppressed the replicon-induced RDVI in adult worms, indicating
that the rescue of the VSR-deficient FR1gfp replicon could serve as
an RDVI suppression assay to identify VSRs in C. elegans following
heat-inducible expression.
We next determined whether RDVI was suppressed by FHV B2
driven by a constitutive promoter. We found that the replication
of FR1gfp was also significantly enhanced in worms constitutively
expressing FHV B2 compared to that in worms constitutively ex-
pressing the B1. However, in comparison, the expression of FHV
B2 utilizing the heat-inducible promoter achieved a stronger res-
cue on FR1gfp replication (Fig. 2D).
The genomic RNA2 of Orsay virus encodes no detectable
RDVI suppression activity. The fact that the replication of Orsay
virus in wild-type N2 worms is suppressed by RDVI and can be
rescued by FHV B2 suggested that Orsay virus encodes weak or no
RDVI suppression activity. To test this hypothesis, we subjected
the putative capsid protein and the delta protein encoded by Orsay
virus genomic RNA2 to the RDVI suppression assay described in
Fig. 2. Our gonad microinjection of plasmid constructs contain-
ing either the capsid protein or the delta protein coding sequence
driven by the heat-inducible promoter (Fig. 3A) generated 17 and
13 lines of transgenic worms, respectively. However, none of these
transgenic lines showed enhanced GFP fluorescence after heat in-
duction (Fig. 3B). This result suggests that none of the two puta-
tive proteins encoded by Orsay virus RNA2 possesses worm RDVI
suppression activity.
NoV B2, but not TBSV p19, TAV 2b, or hypovirus p29, sup-
presses RDVI in C. elegans. Both TBSV p19 and TAV 2b are well-
characterized VSRs of plant origin that specifically bind and suppress
the function of 21-nt siRNA duplexes (9, 13, 14, 17). In particular,
TBSV p19 is known to be functional in heterologous systems such as
insect and mammalian (15–17) and, owing to its target specificity, has
been used as a genetic tool to explore the molecular mechanism of 21
siRNAs or miRNAs (17, 48). The p29 protein encoded by fungus-
infecting hypovirus is another VSR known to be able to suppress
RNAi in heterologous system such as plants (49). Currently, how P29
suppresses RDVI remains largely unknown. To find out whether
these three VSRs retain their RDVI suppression activity in worm, we
subjected all of them to the RDVI suppression assay described in Fig.
2. Our assay also included NoV B2 which, despite sharing limited
sequence identity with FHV B2, adopts a mechanism similar to that
of FHV B2 to suppress RNAi (12), was thus expected to retain the
RDVI suppression activity in worms. Indeed, as shown in Fig. 4A and
B, ectopic expression of NoV B2 utilizing the heat-inducible pro-
moter led to successful rescue of FR1gfp replication, manifested as
significantly enhanced GFP fluorescence, in wild-type N2 worms.
Surprisingly, such a rescue was not observed for ectopic expression of
FIG 2 Ectopic expression of FHV B2 suppresses worm RDVI targeting FR1gfp
replicon. (A) Schematic structure of the FR1gfp replicon, the Pmyo-2::
mcherry reporter construct, and the FHV B1 and B2 transgenes utilizing the
heat-inducible promoter. HIP, heat-inducible promoter; protein A, replicase
of FHV; Rz, self-cleaving ribozyme sequence from hepatitis delta virus; UTR,
3= end untranslated sequence of the worm gene unc-54; Pmyo-2, promoter for
the worm gene myo-2, which directs target gene expression in the pharynx
tissue. (B) Visualization of green fluorescence in worms carrying the FR1gfp
nuclear transgene and extrachromosomal array corresponding to FHV B1 or
FHV B2, as indicated, at 48 h after heat induction. Shown here are merged
images recorded using the same exposure under white light, red fluorescence,
and green fluorescence. Worms showing red or orange (merged from red and
green) color are transgenic for FHV B1 or FHV B2. (C) Accumulation of
FR1gfp genomic and subgenomic RNAs in wild-type N2 worms or worms
carrying the rde-1-null allele (ne300) or integrated transgene corresponding to
FHV B1 or B2 as indicated. Total RNA was prepared at 48 h after heat induc-
tion. The total RNA was hybridized with probes prepared from full-length gfp
cDNA. Methylene blue-stained rRNA serves as an equal loading control. (D)
Accumulation of FR1gfp transcripts in N2 worms expressing FHV B1 or B2
utilizing the sur-5 promoter or the heat-inducible promoter (indicated with
asterisks).
FIG 3 The genomic RNA2 of Orsay virus encodes no RDVI suppression ac-
tivity. (A) Schematic structure of heat-inducible transgenes corresponding to
the putative coat protein (CP) and delta protein of Orsay virus, respectively.
(B) Visualization of green fluorescence in worms carrying the FR1gfp nuclear
transgene and extrachromosomal arrays generated through gonad injection of
HIP::CP or HIP::delta. Worms showing red or orange (merged from red and
green) color carry the HIP::CP or HIP::delta transgene. See Fig. 2 for experi-
ment details.
Suppression of RNAi in C. elegans



























































TBSV p19, TAV 2b, a p19 loss-of-function mutant termed p19m, that
contains the R72G point mutation (50), or hypovirus p29. Consistent
with this observation, enhanced FR1gfp replication was detected by
Northern blotting only in chromosomal integrants containing the
heat-inducible NoV B2 transgene (Fig. 4C).
A previous study suggested that TBSV p19 can be tagged with
an hemagglutinin (HA) epitope tag to the carboxyl terminus (C
terminus) without losing its RNAi suppression activity (17). To
rule out the possibility that the failure of TBSV p19 in suppressing
worm RDVI is a result of instability of this suppressor when pro-
duced in worm, we checked the accumulation of HA-tagged p19
expressed from a heat-inducible transgene, termed HIP::p19HA
(Fig. 4D, upper left panel), using Western blotting. As shown in
the lower left panel of Fig. 4D, the production of HA-tagged p19
can be readily detected 48 h after heat induction in a chromosomal
integrant containing the HIP::p19HA transgene. Like that found
for wild-type TBSV p19, no RDVI suppression activity was de-
tected for this HA-tagged variant (Fig. 4D, right panel). These
results thus confirmed that the failure of TBSV p19 in RDVI sup-
pression is not a result of instability in worms.
To find out whether TBSV p19, TAV 2b, and NoV B2 are able
to suppress dsRNA-triggered RNAi and RDVI targeting Orsay
virus, we checked the gfp transgene silencing triggered by gfp
dsRNA ingestion (see Fig. 1 for details) and Orsay virus replication
in wild-type N2 worms constitutively expressing each of these
suppressors. As shown in Fig. 4E, the suppression on dsRNA-
triggered gfp transgene silencing was only observed in NoV B2-
expressing worms. Consistent with this observation, enhanced
Orsay virus replication, compared to that in wild-type N2 worms,
only occurred in worms transgenic for NoV B2 (Fig. 4F). These
observations together suggested that NoV B2, but not TBSV p19
or TAV 2b, suppresses dsRNA-triggered RNAi and RDVI trig-
gered during natural viral infection in C. elegans.
FHV B2 targets a step downstream of primary siRNA biogen-
esis to suppress RDVI. To better understand the molecular mech-
anism underlying the success/failure of the nodavirus B2s, TBSV
FIG 4 NoV B2, but not TBSV p19 or TAV 2b, suppresses long dsRNA-triggered RNAi and RDVI targeting Orsay virus. (A) Schematic structure of heat-inducible
transgenes corresponding to NoV B2 (nB2), TBSV p19 (p19), TBSV p19m (p19m), TAV 2b (2b), and p29. (B) Visualization of green fluorescence in worms
carrying the FR1gfp replicon transgene and extrachromosomal arrays generated through gonad injection of constructs shown in panel A. Shown here are merged
images recorded under white light, red fluorescence and green fluorescence with the same exposure 48 h after heat induction. (C) Accumulation of FR1gfp
transcripts in transgenic N2 worms carrying the integrated transgenes corresponding to NoV B2, TBSVp19, TBSV p19m, and TAV 2b. p19m, a p19 variant that
contains the R72G point mutation and is known to be deficient in RNAi suppression. (D) HA-tagged TBSV p19 is deficient in RDVI suppression. The upper left
panel shows the structure of a heat-inducible transgene expressing TBSV p19 tagged with HA at the C terminus. The lower left panel shows Western blot detection
of HA-tagged p19 produced in wild-type N2 worms and worms containing the heat-inducible transgene shown in the upper left panel. In the right panel, the
HA-tagged TBSV p19 is deficient in RDVI suppression. Shown here is the accumulation of FR1gfp transcripts detected in wild-type N2 worms and worms
containing the heat-inducible transgene corresponding to HA-tagged p19. Asterisks denote samples prepared using heat-induced worms. (E) NoV B2, but not
TBSV p19 or TAV 2b, suppresses dsRNA-triggered RNAi targeting a gfp transgene. Asterisks denote total RNA samples extracted from worms fed on E. coli food
expressing gfp dsRNA. (F) NoV B2, but not TBSV p19 or TAV 2b, enhances the replication of Orsay virus. Shown here is the accumulation of Orsay virus RNA1
in worms containing NoV B2, TBSV p19, and TAV 2b transgenes, as indicated, utilizing the constitutively active promoter of the sur-5 gene.
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p19, and TAV 2b in worm RDVI suppression, we examined the
accumulation of FR1gfp-derived siRNAs in worms containing
heat-inducible transgene corresponding to each of these VSRs.
Consistent with previous deep-sequencing analysis (51), our
Northern blotting analyses detected discrete primary siRNA
bands, with the major one showing up at the position correspond-
ing to 23 nt in the rde-1 mutants which are known to accumulate
only primary siRNAs (Fig. 5A) (32, 35, 52). As indicated by arrows
in Fig. 5A, our Northern blot analyses also detected an siRNA
band with a size falling between 21 and 22 nt in wild-type N2
worms and worms containing heat-inducible transgene corre-
sponding to FHV B1. However, such an siRNA band was not
detected in single or double mutants containing the rrf-1-null al-
lele. In the light of the fact that rrf-1 functions downstream of
rde-1 to produce 22-nt secondary siRNAs in a Dicer-independent
manner (36–38, 52), we believed that this band represents the
rrf-1-dependent secondary siRNAs. The faster migration rate of
this band compared to the 22-nt primary siRNAs may be a man-
ifestation of the fact that the rrf-1-dependent siRNAs carry a
triphosphate group at the 5= end. FR1gfp-derived siRNAs were
also detected in FHV B2 and NoV B2 transgenic worms with a
pattern similar to that detected in rde-1 mutants (Fig. 5A and B),
suggesting that FHV B2 and NoV B2 inhibit the function, rather
than the biogenesis of, primary siRNAs to suppress RDVI. In
agreement with this notion, the rrf-1-dependent secondary siR-
NAs were not detected in the presence of FHV B2 (Fig. 5A and B).
As shown in Fig. 5A, the accumulation of miR-58 was not reduced
in response to FHV B2 expression compared to that in wild-type
N2 worms or worms expressing FHV B1, suggesting that FHV B2
does not suppress the biogenesis of worm miRNAs.
As shown in Fig. 5C, the rrf-1-dependent siRNAs were also
detected in worms expressing TBSV p19, TAV 2b or their loss-of-
function mutants with a pattern similar to that detected in wild-
type N2 worms. However, it is interesting that despite of the fact
that none of TBSV p19, TAV 2b and their loss-of-function mu-
tants exhibited RDVI suppression activity in our FR1gfp replica-
tion rescue assays (Fig. 4), a slightly enhanced accumulation of
22-nt primary siRNAs was detected in worms expressing wild-
type TBSV p19 or TAV 2b compared to worms expressing respec-
tive loss-of-function mutants (Fig. 5C).
To find out whether FR1gfp-derived siRNAs detected in the
presence of FHV B2 are bona fide primary siRNA duplexes pro-
duced by worm Dicer, we treated our small RNA samples with
Terminator exonuclease, which destroys single-stranded RNAs
carrying a monophosphate group at the 5= end but is much less
efficient in digesting siRNA duplexes carrying monophosphate at
the 5= end (53). As expected, our Terminator treatment destroyed
FIG 5 FHV B2 targets a step downstream of the primary siRNA biogenesis to
suppress RDVI. (A) Accumulation of FR1gfp-derived siRNAs, detected by
Northern blotting, in worms containing heat-inducible transgene correspond-
ing to FHV B1 or FHV B2 and wild-type N2 worms and single and double
mutants defective in rde-1 and/or rrf-1 function as indicated. After the detec-
tion of the virus-derived siRNAs, the same filter membrane was reused, after
stripping, for the detection of miR-58 miRNAs. M, four DNA oligonucleotides
with different sizes as indicated. They were detected using DIG-labeled cDNA
oligonucleotides and, together with miR-58, served as size references. The
accumulation of miR-58 in each sample also served as an equal loading con-
trol. Arrows indicate the rrf-1-dependent siRNAs. (B) Accumulation of
FR1gfp-derived siRNAs in rde-1 mutants and worms containing heat-induc-
ible FHV B2 or NoV B2 transgenes. (C) Accumulation of FR1gfp-derived
siRNAs in rrf-1 mutants and worms containing heat-inducible transgenes cor-
responding to, as indicated, TBSV p19, TAV 2b, or their loss-of-function mu-
tants. 2bm, a loss-of-function mutant of TAV 2b that contains the P41A point
mutation (9). To obtain a size reference and equal loading control, the same
filter membrane was reprobed for the detection of miR-58 miRNAs. (D)
Northern blot detection of FR1gfp-derived siRNAs in transgenic N2 worms
containing heat-inducible transgenes corresponding to various VSRs, as indi-
cated, after treatment with the Terminator exonuclease. After the detection of
the virus-derived siRNAs, the same filter membrane was reused for the detec-
tion of miR-58 miRNAs to generate size reference and equal loading control
and Terminator treatment effectiveness control. Asterisk denotes samples not
treated with the Terminator exonuclease.
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the miR-58 miRNAs in all small RNA samples (compare the
treated samples to the untreated fB1 and fB2 small RNA samples)
(Fig. 5D). However, such a treatment generated no detectable im-
pact to the abundance of siRNAs detected in rde-1 mutants or
worms expressing the FHV B2. This result thus suggested that the
siRNAs detected in the presence of FHV B2 are bona fide primary
siRNA duplexes.
FHV B2 does not inhibit the function of worm miRNAs. In
plants, VSRs are capable of interfering with the function of
miRNAs, leading to development defects (19, 21, 22). The C. el-
egans genome encodes a single Dicer that is required for the bio-
genesis of both siRNAs and miRNAs (54, 55). The fact that the
accumulation of miR-58 is not affected in worms expressing FHV
B2 (Fig. 5A and B) suggested that FHV B2 does not suppress the
biogenesis of worm miRNAs. However, the fact that heat-induc-
ible expression of FHV B2 exhibited stronger suppression on
RDVI, compared to constitutive expression (Fig. 2D), suggested a
hypothesis that constitutive expression of FHV B2 leads to the
suppression on miRNA function such that worms constitutively
expressing FHV B2 at high level failed to develop and thus were
selected out. To test this hypothesis, we checked the suppression
activity of FHV B2 on miRNA function using an assay system
developed previously (46). This assay system features a myo-2 pro-
moter driven gfp transgene containing the let-7 target sequences
within the 3=-end untranslated region. Thus, suppression of
miRNA function will result in enhanced green fluorescence in the
pharynx tissue which can be easily identified.
We used the myo-2 promoter to drive the expression of FHV
B2 and the control protein FHV B1 in our assay to ensure that
both transgenes will have the same tissue-specific expression pat-
tern as the gfp reporter gene (Fig. 6A). To ensure that functional
FHV B2 proteins are produced in the pharynx tissue, we checked
the suppression activity of FHV B2 on RNAi triggered by two
transgenes that produce complementary transcripts within the
pharynx tissue. As shown in Fig. 6A, the Pmyo-2::GFP construct
contains a GFP coding sequence under the control of myo-2 pro-
moter, whereas the Pmyo-2::PFG construct contains a sequence
complementary to the GFP coding sequence under the control of
the same myo-2 promoter. Thus, codelivery of Pmyo-2::GFP and
Pmyo-2::PFG constructs is expected to trigger gfp silencing in
wild-type N2 worms. Indeed, as shown in Fig. 6B, a transgenic
locus containing both Pmyo-2::GFP and Pmyo-2::PFG transgenes
produced weak green fluorescence in wild-type N2 worms but
bright green fluorescence in rde-4 mutants. Enhanced green fluo-
rescence produced by the same transgenic locus was also observed
in wild-type N2 worms containing the Pmyo-2::fB2 transgene.
However, such an enhancement in green fluorescence was not
observed in the presence of the Pmyo-2::fB1 transgene, confirm-
ing that the Pmyo-2::fB2 transgene produces functional FHV B2
in the pharynx tissue.
To find out whether FHV B2 suppresses the function of
miRNAs, we injected the wild-type N2 worms carrying the gfp
reporter transgene with Pmyo-2::fB1 or Pmyo-2::fB2 constructs.
Subsequently, we checked the production of green fluorescence in
worms containing extrachromosomal arrays corresponding to
Pmyo-2::fB1 or Pmyo-2::fB2. As shown in Fig. 6C, no enhanced
green fluorescence was observed in response to ectopic expression
of either FHV B1 or FHV B2, suggesting that FHV B2 does not
interfere with the function of miRNAs in C. elegans.
DISCUSSION
RDVI represents a major antiviral mechanism in fungi, plants,
and insects (2). To survive, many viruses produce diverse classes,
in terms of sequence and structure, of VSRs that suppress RDVI
through distinct mechanisms (1, 7). Since VSRs can target and
suppress RNAi directed by endogenous siRNAs and miRNAs
studies on the VSR-mediated virus-host interactions have not
only significantly improved our understanding of the evolution-
ary arm race between viruses and their natural hosts but also al-
lowed us to gain insight into the mechanistic basis underlying
disease induction by virus infection in the aforementioned sys-
tems (7, 15, 22). The nematode worm C. elegans has recently
emerged as an important animal model for the study of virus-host
interaction in single-Dicer invertebrates. Thus far, the study on
VSR-mediated virus-nematode host interaction, especially the in-
teraction that leads to disease development, has remained to be an
unexplored field mainly owing to the fact that a robust RDVI
suppression assay has yet to be developed for the identification of
VSRs with worm RDVI suppression activity. Here, we reported a
worm RDVI suppression assay system developed using FHV B2 as
a reference VSR. Because a viral replicon is used as both trigger
and target of RDVI, our assay system is expected to identify VSRs
with true function in RDVI suppression. Using this assay we have
successfully identified NoV B2, which shares limited sequence ho-
mology with FHV B2 but uses similar mechanism in RDVI sup-
FIG 6 FHV B2 does not inhibit miRNA function. (A) Schematic structure of
the myo-2 promoter-based constructs. PFG, antisense of GFP coding se-
quence. (B) FHV B2 suppresses RNAi in the pharynx tissue. Shown here is the
green fluorescence in pharynx tissue in wild-type N2 worms, rde-4 mutants,
and worms containing Pmyo-2::fB1 or Pmyo-2::fB2 transgene as indicated. All
worms used in this test contain a nuclear transgene generated by coinjection of
Pmyo-2::GFP and Pmyo-2::PFG. The images were produced by merging im-
ages recorded using the same exposure under white light, red fluorescence, or
green fluorescence. (C) FHV B2 does not suppress miRNA function in C.
elegans. Shown here is the green fluorescence in the pharynx tissue in wild-type
N2 worms and worms containing extrachromosomal array corresponding to
Pmyo-2::fB1 or Pmyo-2::fB2 as indicated. The images were produced by merg-
ing images recorded under white light or green fluorescence with the same
exposure. The insets are images recorded under white light.
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pression, as another VSR that retains RDVI suppression activity in
the worm system, confirming the robustness of our assay system.
Thus, our assay system for the first time makes it possible to iden-
tify VSRs with worm RDVI suppression activity. It can be expected
that functional and mechanistic characterization of VSRs identi-
fied using our assay will help unravel some unique features of
VSR-mediated virus-nematode worm interaction.
Unlike plants and insects, the nematode worm C. elegans uses a
single Dicer to initiate both RDVI and other RNAi-related path-
ways. Moreover, the worm RDVI pathway features some unique
components, such as RSD-2 and DRH-1 (32), and is known to
require RRF-1, an RdRP that produces 22-nt single-stranded sec-
ondary siRNAs in a Dicer-independent manner (32, 37, 38, 52).
These observations make it interesting to ask whether the worm
RDVI responds differently to VSRs identified in heterologous sys-
tems. To address this question, we assayed the RDVI suppression
activity for VSRs encoded by fungus, plant, and insect viruses in C.
elegans. Our results clearly showed that, in addition to FHV B2,
NoV B2, but not the p19 or 2b proteins encoded by plant viruses
or the p29 protein-encoded fungus virus, suppresses RDVI trig-
gered by replicating viruses (Fig. 1, 2, 3, and 4). Interestingly,
however, unlike that in plants and insects, FHV B2 appears to
target a step downstream of primary siRNA, but upstream of sec-
ondary siRNA, biogenesis to suppress RNAi (Fig. 5A and D).
These results together not only confirmed that worm RDVI in-
deed responds differently to heterologous VSRs but also shed light
on some unique mechanistic features of worm RDVI as discussed
below.
Probably due to an siRNA degradation mechanism (42), the
abundance of virus-derived siRNAs is extremely low in C. elegans.
Using a newly developed Northern blotting protocol (29), we
managed to detect virus-derived siRNAs at an unprecedented res-
olution. Consistent with previous deep-sequencing analysis (51),
our Northern blotting analyses detected several viral siRNA
bands, with the major one detected with a size of 23 nt, in rde-1
mutants (Fig. 5A). We believed that these viral siRNAs are bona
fide primary siRNA duplexes produced by the worm Dicer, con-
sidering the facts that the primary siRNAs produced by worm
Dicer are predominantly 23 nt in size (56), rde-1 mutants are
known to accumulate only primary siRNAs (35), and the detected
viral siRNAs are resistant to Terminator exonuclease, which de-
stroys single-stranded RNA molecules with 5= end monophos-
phate group, such as miRNAs, but is much less efficient in digest-
ing siRNA duplexes (Fig. 5D). Our Northern blotting analyses also
detected an rrf-1-dependent siRNA band with a size falling be-
tween 21 and 22 nt (Fig. 5A and C). The unique migration pattern
of these rrf-1-dependent siRNAs may simply reflect the fact that,
although 22 nt in size (36–38), rrf-1-dependent siRNAs carry a
triphosphate, instead of a monophosphate, group at the 5= end
and thus are expected to migrate faster than the 22-nt primary
siRNAs which carry monophosphate group at the 5= end.
FHV B2 is a versatile VSR that suppresses RNAi in diverse
organisms (16, 26, 47). Previous biochemical and structural stud-
ies suggested that FHV B2 forms homodimers and binds to
dsRNA without a length preference (8, 10, 11). These observations
suggested that FHV B2 could have dual modes of action in RDVI
suppression: inhibiting Dicer-processing of dsRNAs or interfering
with the function of siRNAs (8). Previously, it has been shown that
the major mode of action of B2 in plants and insects is to suppress
the biogenesis of siRNAs (47, 57). Currently, it remains unclear
whether FHV B2 actively suppresses RDVI by inhibiting the func-
tion of siRNAs. Here, we show that FR1gfp-derived siRNAs in
worms expressing FHV B2 can be detected at a comparable
amount and with a similar pattern as that in rde-1 mutants (Fig.
5A). Since rde-1 mutant is known to be defective in the biogenesis,
but not the function, of primary siRNAs (35), this observation
suggests that the major mechanism of FHV B2 in worm RDVI
suppression is to inhibit the function, thus the biogenesis of sec-
ondary siRNAs, of primary siRNAs. In supporting this notion, the
rrf-1-dependent secondary siRNAs became undetectable in
worms expressing FHV B2 (Fig. 5A and B). Worm RDVI pathway
contains some unique components such as DRH-1. Considering
the fact that the mammalian counterparts of DRH-1 function as
cytosolic virus sensors, it is possible that DRH-1 functions as a
virus sensor to facilitate the viral dsRNA acquisition by worm
Dicer. As a result, the biogenesis of viral primary siRNAs can be
significantly enhanced even in the presence of FHV B2. However,
since FHV B2 can inhibit the function of primary siRNAs and the
biogenesis of secondary siRNAs, the targeted viruses will still be
able to replicate efficiently in the presence of FHV B2, as revealed
here.
TBSV p19 is a well-characterized VSR of plant origin that can
suppress RNAi in heterologous systems such as insects and mam-
mals (17, 26). Previous studies suggested that both TBSV p19 and
TAV 2b specifically bind and inhibit the function of 21-nt siRNAs
to suppress RNAi. Although siRNA duplexes of other sizes can
also be bound by these two VSRs, the binding affinity diminishes
rapidly with increasing size differences (9, 13, 14). In fact, because
of its target specificity TBSV p19 has been used as a universal RNAi
suppressor to explore the molecular mechanism of 21-nt siRNAs
and miRNAs (17, 48). We show here that, although successfully
expressed in C. elegans, TBSV p19 failed to suppress long dsRNA-
triggered RNAi, RDVI triggered by two unrelated viruses, and the
biogenesis of RRF-1-dependent secondary siRNAs. This finding
suggests that virus-derived 21-nt primary siRNAs, which, unlike
the 22- and 23-nt primary siRNAs, can only be detected in some
RDVI mutants (Fig. 5A and C), do not make major contribution
to RDVI in C. elegans.
In plants, VSRs can interfere with the function of miRNAs,
which usually form near-perfect sequence matches with their pas-
senger strands, resulting in developmental defects or diseases (19,
22). Animal miRNAs and their passenger strands often do not
form near-perfect sequence matches and thus have been shown to
be resistant to the inhibitory effect of VSRs produced in drosoph-
ila (15, 16). Currently, it remains unclear whether VSRs are able to
interfere with the biogenesis and/or function of miRNAs in the
nematode kingdom, which uses a single Dicer to initiate both
siRNA and miRNA pathways. In this report, we show that FHV B2
is unable to suppress the biogenesis and function of miRNAs in C.
elegans (Fig. 5 and 6). This is the first demonstration that VSRs
selectively suppress siRNA, but not miRNA, function in organ-
isms that use single Dicer to produce both siRNAs and miRNAs.
Previously, endogenous siRNAs that function in transposon
control in drosophila have been shown to be susceptible to the
inhibitory effect of VSRs (15). Recently, worm endogenous
siRNAs have been shown to contribute to normal cellular function
by maintaining wide-spread gene silencing, together with
piRNAs, a class of endogenous small RNAs whose biogenesis does
not require Dicer (58). Thus, it was expected that functional inhi-
bition of these endogenous siRNAs by nodavirus B2 proteins,
Suppression of RNAi in C. elegans



























































which appears to inhibit the function of virus-derived siRNAs as
shown in Fig. 5, will induce developmental defects in worms. Thus
far, we have not observed any developmental defects associated
with constitutive expression of the B2 VSRs. However, it remains
possible that the inhibitory effect of the B2 proteins on worm
endogenous siRNAs takes much longer time to develop or needs a
specific bioassay to identify. Alternatively, strong inhibition of
endogenous siRNA function may have resulted in lethal embryos
and, as a result, only transgenic animals expressing the B2 proteins
at low level can survive. In supporting this hypothesis, transgenic
lines carrying constitutively expressed FHV B2 transgene showed
weaker FR1gfp replication rescue compared to those carrying
heat-inducible FHV B2 transgene (Fig. 2D). Nevertheless, our
study suggested that some heterologous VSRs, such as the FHV
B2, can retain their functional specificity in the worm system,
making it possible to use these VSRs as genetic tools to study the
biogenesis and function of worm endogenous siRNAs.
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